Bioregenx (BRGX) Total Current Liabilities (2021 - 2026)

Bioregenx's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $4.0 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 5.38% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 5.38% YoY), while the FY2025 annual figure was $4.1 million, up 11.92% from the prior year.
• Total Current Liabilities was $4.0 million for Q1 2026 at Bioregenx, down from $4.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $4.1 million in Q4 2025 to a low of $39112.0 in Q1 2023.
• Historically, Total Current Liabilities has averaged $2.6 million across 5 years, with a median of $3.5 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Total Current Liabilities surged 8553.83% in 2024, then gained 5.38% in 2026.
• A 5-year view of Total Current Liabilities shows it stood at $64880.0 in 2022, then jumped by 4195.9% to $2.8 million in 2023, then soared by 30.35% to $3.6 million in 2024, then gained by 11.92% to $4.1 million in 2025, then retreated by 1.93% to $4.0 million in 2026.
• The last three Total Current Liabilities figures came in at $4.0 million (Q1 2026), $4.1 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.